Vertex Pharmaceuticals' SWOT analysis: biotech giant's stock faces growth challenges
Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...
eLife3 天
Single-cell sequencing provides clues about the developmental genetic basis of evolutionary ...
This study provides a valuable new resource to investigate the molecular basis of the particular features characterizing the pipefish embryo. The authors found both unique and shared gene expression ...
T-Mobile Is Expanding Its Starlink Beta to iPhones and Pixels
T-Mobile is expanding its Starlink beta program. Now, some iPhone, Samsung Galaxy, and Google Pixel users can connect to ...
Pixel 9 users report access to the T-Mobile Starlink satellite messaging beta
Satellite messaging through Starlink supports "medium resolution images, music & audio podcasts," in a comment by Musk. With ...
What's Happening With VRTX Stock?
With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...
Pharmaceutical Technology6 天
NHS England to offer Casgevy for sickle cell disease patients
The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...